Healthpeak Properties (NYSE:DOC) Reaches New 12-Month High Following Analyst Upgrade

Healthpeak Properties, Inc. (NYSE:DOC) shares reached a new 52-week high on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $18.00 to $21.00. JPMorgan Chase & Co. currently has a neutral rating on the stock. Healthpeak Properties traded as high as $20.87 and last traded at $20.8750, with a volume of 4584874 shares traded. The stock had previously closed at $20.56.

DOC has been the topic of a number of other research reports. BMO Capital Markets lifted their price target on shares of Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, June 15th. Wells Fargo & Company raised their target price on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a research note on Monday, June 1st. Morgan Stanley reiterated an “equal weight” rating and issued a $22.00 target price (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Scotiabank boosted their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research report on Wednesday, May 27th. Finally, Robert W. Baird upped their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. Three equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $19.93.

Insider Activity at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the sale, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.23% of the stock is currently owned by company insiders.

Institutional Trading of Healthpeak Properties

Hedge funds have recently bought and sold shares of the stock. WPG Advisers LLC raised its holdings in shares of Healthpeak Properties by 270.2% in the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after buying an additional 1,197 shares in the last quarter. Advocate Investing Services LLC bought a new stake in Healthpeak Properties in the fourth quarter valued at $26,000. Elyxium Wealth LLC bought a new stake in Healthpeak Properties in the fourth quarter valued at $31,000. Clearstead Advisors LLC raised its stake in Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after acquiring an additional 1,216 shares in the last quarter. Finally, CYBER HORNET ETFs LLC acquired a new position in Healthpeak Properties during the second quarter worth $33,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Stock Performance

The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a fifty day simple moving average of $18.80 and a 200-day simple moving average of $17.58. The company has a market capitalization of $14.34 billion, a P/E ratio of 65.11, a PEG ratio of 3.11 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The business had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts forecast that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be paid a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 5.9%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties’s dividend payout ratio is currently 381.25%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.